1. Home
  2. LFMD vs ABEO Comparison

LFMD vs ABEO Comparison

Compare LFMD & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LFMD
  • ABEO
  • Stock Information
  • Founded
  • LFMD 1994
  • ABEO 1974
  • Country
  • LFMD United States
  • ABEO United States
  • Employees
  • LFMD N/A
  • ABEO N/A
  • Industry
  • LFMD Medical/Nursing Services
  • ABEO Biotechnology: Pharmaceutical Preparations
  • Sector
  • LFMD Health Care
  • ABEO Health Care
  • Exchange
  • LFMD Nasdaq
  • ABEO Nasdaq
  • Market Cap
  • LFMD 330.5M
  • ABEO 281.0M
  • IPO Year
  • LFMD N/A
  • ABEO 1980
  • Fundamental
  • Price
  • LFMD $6.34
  • ABEO $5.51
  • Analyst Decision
  • LFMD Buy
  • ABEO Strong Buy
  • Analyst Count
  • LFMD 6
  • ABEO 6
  • Target Price
  • LFMD $12.50
  • ABEO $18.17
  • AVG Volume (30 Days)
  • LFMD 979.6K
  • ABEO 1.0M
  • Earning Date
  • LFMD 11-06-2025
  • ABEO 11-13-2025
  • Dividend Yield
  • LFMD N/A
  • ABEO N/A
  • EPS Growth
  • LFMD N/A
  • ABEO N/A
  • EPS
  • LFMD N/A
  • ABEO 0.99
  • Revenue
  • LFMD $245,563,670.00
  • ABEO $400,000.00
  • Revenue This Year
  • LFMD $21.50
  • ABEO N/A
  • Revenue Next Year
  • LFMD $17.18
  • ABEO $324.71
  • P/E Ratio
  • LFMD N/A
  • ABEO $5.54
  • Revenue Growth
  • LFMD 37.74
  • ABEO N/A
  • 52 Week Low
  • LFMD $3.99
  • ABEO $3.93
  • 52 Week High
  • LFMD $15.84
  • ABEO $7.54
  • Technical
  • Relative Strength Index (RSI)
  • LFMD 47.97
  • ABEO 47.59
  • Support Level
  • LFMD $5.97
  • ABEO $5.29
  • Resistance Level
  • LFMD $6.52
  • ABEO $5.60
  • Average True Range (ATR)
  • LFMD 0.28
  • ABEO 0.25
  • MACD
  • LFMD -0.00
  • ABEO 0.05
  • Stochastic Oscillator
  • LFMD 38.10
  • ABEO 58.57

About LFMD LifeMD Inc.

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Share on Social Networks: